Press release
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2034 | Key Players: Johnson & Johnson Services Inc; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhance medication adherence by addressing swallowing difficulties and providing faster onset of action, making them ideal for conditions requiring quick relief, such as allergies or migraines.For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=10142
The market's expansion is further supported by advancements in formulation technologies and rising healthcare expenditures, positioning ODTs as a preferred alternative to traditional tablets in pharmaceutical portfolios.
Market Segmentation and Trends:
The ODT market is segmented by drug class, distribution channel, and region, offering a detailed view of its dynamics. Drug classes include anti-psychotics, anti-epileptics, CNS stimulants, anxiolytics, anti-Parkinsonian drugs, anti-hypertensives, NSAIDs, anti-allergy drugs, proton pump inhibitors, and others. Anti-psychotics lead with a 2024 valuation of USD 4.72 billion, projected to reach USD 15.76 billion by 2034 at a 12.8% CAGR, driven by improved patient compliance in mental health treatments. CNS disease-related ODTs, valued at USD 14.15 billion in 2024, are expected to grow to USD 46.17 billion at a 12.6% CAGR, benefiting from rapid absorption for neurological conditions.
Distribution channels comprise hospital pharmacies, retail pharmacies, drug stores, and online pharmacies, with hospital pharmacies forecasted to expand at a 12.7% CAGR, fueled by rising inpatient care needs. Regionally, North America holds a 37.1% share in 2024, while Latin America is anticipated to account for 3.4% by 2034. Trends include the adoption of taste-masking technologies and super disintegrants to enhance palatability, alongside freeze-drying methods for improved stability and shelf life.
Driving Factors Behind Market Growth:
The ODT market is propelled by several key factors. The aging global population, prone to dysphagia and muscle weakness, increases demand for easy-to-swallow formulations that eliminate choking risks and require no water. Rapid dissolution on the tongue ensures faster absorption, aiding quicker recovery in conditions like epilepsy and neurological disorders. Enhanced patient adherence is a significant driver, as ODTs improve compliance among pediatric and geriatric patients through better taste and convenience. The prevalence of chronic diseases, such as mental health disorders and allergies, further boosts adoption, with ODTs offering precise dosing and reduced gastrointestinal irritation.
Technological advancements in formulation, including oral antivirals and solid dosage forms, support market growth. Additionally, strategic collaborations between pharmaceutical companies and contract manufacturing organizations (CMOs) facilitate innovative product development, addressing diverse therapeutic needs and expanding market reach.
Browse Full Report: https://www.factmr.com/report/orally-disintegrating-tablet-market
Recent Developments and Key Players:
The ODT market is competitive, with key players focusing on innovation, partnerships, and portfolio expansions to capture share. Recent developments emphasize advanced formulations for better taste and disintegration speed. For instance, collaborations with CMOs have led to novel ODTs for oral antivirals, enhancing market offerings. Companies are investing in R&D to improve stability and patient acceptance, particularly in Brazil, where taste-masking and freeze-drying technologies are gaining traction.
Key players include Johnson & Johnson Services Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Eli Lily and Company, Dr. Reddy's Laboratories Ltd., Mylan N.V., Bausch Health, GlaxoSmithKline Plc, Merck & Co Inc., AstraZeneca, Bayer AG, and F. Hoffmann-La Roche Ltd. Competitor analysis reveals strategies like mergers, acquisitions, and geographical expansions to maintain dominance. Teva and Sun Pharma lead in generics with cost-effective ODTs, while Johnson & Johnson and Takeda focus on branded innovations for CNS and anti-psychotic segments. Pricing, sales growth, and technological advancements are key competitive factors, with firms leveraging production capacity to meet rising demand.
Regional Insights and Opportunities:
North America dominates with a 37.1% market share in 2024, driven by high chronic disease prevalence and demand for patient-centric formulations in the United States. Latin America offers growth potential, with Brazil's market valued at USD 397 million in 2024, projected to reach USD 1.01 billion by 2034 at a 9.8% CAGR, supported by advancements in palatability and stability. Chile is expected to expand at a 9.9% CAGR, holding a 21.5% regional share by 2034. Europe benefits from robust pharmaceutical R&D, while Asia Pacific, including India and China, shows promise due to increasing healthcare access. The Middle East & Africa present opportunities through rising awareness and infrastructure improvements. Strategic partnerships and localized manufacturing are key to tapping underpenetrated markets.
Challenges and Future Outlook:
The ODT market faces challenges, including high development costs for taste-masking and stability enhancements, regulatory hurdles for bioequivalence, and competition from traditional dosage forms. Limited awareness in developing regions and supply chain issues for excipients pose additional obstacles. However, the market's future is optimistic, with opportunities in expanding therapeutic applications and digital integration for adherence tracking.
Innovations in super disintegrants and collaborations will drive growth. As patient compliance becomes paramount, the ODT market is well-positioned to nearly triple by 2034, revolutionizing drug delivery through convenient, effective solutions.
Check out More Related Studies Published by Fact.MR:
Rhizoma Gastrodiae Tablets Market https://www.factmr.com/report/rhizoma-gastrodiae-tablets-market
Oral Solid Dosage Pharmaceutical Market https://www.factmr.com/report/oral-solid-dosage-pharmaceutical-market
Active Pharmaceutical Ingredient Market https://www.factmr.com/report/active-pharmaceutical-ingredient-market
Pharmaceuticals & Medicine Manufacturing Market https://www.factmr.com/report/pharmaceuticals-and-medicine-manufacturing-market
Traditional Chinese Medicine for Skincare Market https://www.factmr.com/report/traditional-chinese-medicine-for-skincare-market
Telemedicine Market https://www.factmr.com/report/telemedicine-market
Pharmacogenomic (PGx) Testing Market https://www.factmr.com/report/3143/pharmacogenomic-pgx-testing-market
Compounding Pharmacy Market https://www.factmr.com/report/compounding-pharmacy-market
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2034 | Key Players: Johnson & Johnson Services Inc; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited here
News-ID: 4163816 • Views: …
More Releases from Fact.MR

Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CA …
The global Fine Blanking Tools Market is set for steady growth over the next decade, driven by rising demand for high-precision components, ongoing industrial automation, and surging requirements from automotive, electronics, and aerospace sectors. According to a recent forecast, the market is expected to grow from approximately USD 948.1 million in 2025 to USD 1,430.6 million by 2035, at a compound annual growth rate (CAGR) of about 4.2 % between…

Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; …
The global benzodiazepine drugs market is projected to expand in the coming decade, driven by growing incidence of anxiety, insomnia, alcohol-withdrawal disorders, and advances in pharmaceutical formulations. According to a recent Fact.MR report, the market was valued at approximately USD 2.35 billion in 2022, and is expected to grow at a compound annual growth rate (CAGR) of 2.8% to reach USD 3.1 billion by 2032.
Market Drivers & Outlook
The demand for…

Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Adva …
The global Ultrasound Systems Market is on a strong growth trajectory, projected to rise from USD 10.8 billion in 2025 to approximately USD 19.7 billion by 2035, expanding at a CAGR of 6.2% during the forecast period. This growth is fueled by the rising demand for non-invasive diagnostic imaging, the increasing prevalence of chronic diseases, expanding healthcare infrastructure, and continuous technological innovations such as AI integration and portable imaging systems.
Key…

Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethico …
The global Surgical Staplers Market is forecast to show strong growth over the next decade, nearly doubling in value as demand surges for efficient, reliable wound closure in advanced surgical procedures. According to the latest Fact.MR Surgical Staplers Market Size & Share Forecast Outlook 2025-2035 report, the market is expected to grow from USD 6.0 billion in 2025 to USD 12.5 billion by 2035, at a compound annual growth rate…
More Releases for ODT
Phase 3 Clinical Trial for Major Depressive Disorder Treatment Market Begins 202 …
The Global Major Depressive Disorder Market size reached US$ 6.84 billion in 2024 and is expected to reach US$ 14.57 billion by 2033, growing at a CAGR of 8.8% during the forecast period 2025-2033.
The Major Depressive Disorder Market report, released by DataM Intelligence, offers comprehensive insights and thorough analysis of major market trends, growth prospects, and emerging challenges. With a strong focus on actionable intelligence, DataM Intelligence equips businesses with…
Orally Disintegrating Tablet (ODT) Market Analysis, Size, Current Scenario and F …
Orally disintegrating tablet (ODT) market is anticipated to grow at a significant CAGR during the forecast period. According to the US Food and Drug Administration (FDA), ODT's are a solid dosage form that contains a medicinal substance or active ingredient which rapidly disintegrates when placed upon the tongue within a second. The major factor for the growth of the global orally disintegrating tablet (ODT) market during the forecast period is…
Orally Disintegrating Tablet (ODT) Market Share 2021 Growth Challenges, Opportun …
The global orally disintegrating tablet (ODT) market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). According to the US Food and Drug Administration (FDA), ODT’s are a solid dosage form that contains a medicinal substance or active ingredient which rapidly disintegrates when placed upon the tongue within a second. The major factor for the growth of the global orally disintegrating tablet (ODT) market during the…
Orally Dissolving Tablets (ODT) Excipient Market global outlook and forecast 202 …
The Global Orally Dissolving Tablets (ODT) Excipient Market research report is a careful examination of the worldwide industry which has been a region of enthusiasm for a Orally Dissolving Tablets (ODT) Excipient makers, organizations, authorities, chiefs, and likely speculators, and analysts. The report profoundly lights up noteworthy features in the business, including a contention situation, condition, portions, showcase size, share, gainfulness, development potential, and…
Investigation announced for Long-Term Investors in shares of Odonate Therapeutic …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Odonate Therapeutics, Inc..
Investors who are current long term investors in Odonate Therapeutics, Inc. (NASDAQ: ODT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: ODT stocks follows a lawsuit filed against Odonate…
Deadline on Nov. 16th coming up in Lawsuit for Investors in Odonate Therapeutics …
The Shareholders Foundation announced that a deadline is coming up on November 16, 2020 in the lawsuit filed for certain investors of Odonate Therapeutics, Inc. (NASDAQ: ODT) over alleged securities laws violations by Odonate Therapeutics, Inc.
Investors who purchased shares of Odonate Therapeutics, Inc. (NASDAQ: ODT) have certain options and there are strict and short deadlines running. Deadline: November 16, 2020. NASDAQ: ODT stockholders should contact the Shareholders Foundation at…